A Randomized, Observer Blinded, Controlled Trial to Evaluate the Safety and Immunogenicity of a New Formulation of Euvichol (Killed Bivalent Whole Cell Oral Cholera Vaccine Manufactured by EuBiologics Co. Ltd.) in Healthy Individuals
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Dec 2015
At a glance
- Drugs Cholera vaccine (Primary) ; Euvichol (Primary)
- Indications Cholera
- Focus Pharmacodynamics
- 16 Dec 2015 Planned End Date changed from 1 Apr 2016 to 1 Aug 2016 as per ClinicalTrials.gov record.
- 16 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016 as per ClinicalTrials.gov record.
- 16 Dec 2015 Planned initiation date changed from 1 Oct 2015 to 1 Mar 2016 as per ClinicalTrials.gov record.